Nomura Holdings
JAZZ icon

Nomura Holdings’s Jazz Pharmaceuticals JAZZ Stock Holding History

Nomura Holdings’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-100,000
Closed -$14.5M – 1528
2017
Q1 		$14.5M Buy
+100,000
New +$13M 0.04% 214

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Nomura Holdings's JAZZ Position: Q2 2026 in Review

Nomura Holdings reduced its Jazz Pharmaceuticals (JAZZ) stake by 65% in Q2 2026, selling an estimated $8.5M and leaving 21,352 shares worth $5.15M. The position accounts for 0.01% of the portfolio, ranked #779.

Nomura Holdings first reported a position in JAZZ in Q2 2013 and has held it in 37 quarters since. The position peaked at $11.4M in Q1 2026. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Nomura Holdings held 21,352 shares of Jazz Pharmaceuticals worth $5.15M as of Q2 2026.
  • Nomura Holdings sold 38,799 Jazz Pharmaceuticals shares in Q2 2026, an estimated $8.5M.
  • Jazz Pharmaceuticals made up 0.01% of Nomura Holdings's portfolio in Q2 2026, its #779 holding.
  • Nomura Holdings first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 37 quarters since.
  • Nomura Holdings's Jazz Pharmaceuticals position peaked at $11.4M in Q1 2026.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.